title: Do selective estrogen receptor modulators treat cervical precancer and cancer? Time to pool data from relevant trials.
authors.forename: Philip E
authors.initials: PE
authors.lastname: Castle
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use*; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use*; D016896:Treatment Outcome; D014594:Uterine Neoplasms / Q000188:drug therapy*
chemical_list: D020845:Selective Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride
references.citation: JAMA. 2006 Jun 21;295(23):2727-41
references.pmid: 16754727
references.citation: Lancet Oncol. 2008 May;9(5):425-34
references.pmid: 18407790
references.citation: J Natl Cancer Inst. 1998 Sep 16;90(18):1371-88
references.pmid: 9747868
references.citation: J Natl Cancer Inst. 2009 Mar 18;101(6):384-98
references.pmid: 19276457
references.citation: Cochrane Database Syst Rev. 2000;(2):CD001318
references.pmid: 10796771
references.citation: Expert Rev Anticancer Ther. 2009 Jul;9(7):895-903
references.pmid: 19589029
references.citation: Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):792-800
references.pmid: 19258470
references.citation: Lancet Oncol. 2009 Oct;10(10):975-80
references.pmid: 19796749
references.citation: Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19467-72
references.pmid: 19901334
references.citation: Nat Rev Cancer. 2006 May;6(5):360-8
references.pmid: 16633364
references.citation: Lancet. 2008 Jan 5;371(9606):29-40
references.pmid: 18177773
references.citation: Lancet. 2007 Nov 10;370(9599):1609-21
references.pmid: 17993361
references.citation: Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2490-5
references.pmid: 15699322
references.citation: BMJ. 2008 Sep 18;337:a1284
references.pmid: 18801868
references.citation: Lancet. 2007 Sep 8;370(9590):890-907
references.pmid: 17826171